Platelets and coronary artery disease: Interactions with the blood vessel wall and cardiovascular devices

Markus Reinthaler1, Steffen Braune2, Andreas Lendlein3

  • 1Department for Cardiology, Charité Universitätsmedizin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany; Institute of Biomaterial Science and Berlin-Brandenburg Centre for Regenerative Therapies (BCRT), Helmholtz Zentrum Geesthacht, Kantstrasse 55, 14513 Teltow, Germany; and Joint Laboratory HZG/Charité-FUB, Kantstr. 55, 14513 Teltow, Germany.

Biointerphases
|June 10, 2016
PubMed

Insights

Platelet function is crucial in atherosclerosis and thromboembolic events. This review details platelet structure and function in atherosclerotic patients and after cardiovascular device implantation.

Area of Science:

  • Cardiovascular Research
  • Hematology
  • Biomedical Engineering

Background:

  • Atherosclerosis involves complex thromboembolic events.
  • Platelet function is a significant, yet understudied, risk factor in atherosclerosis.
  • Cardiovascular device implantation can alter platelet behavior.

Purpose of the Study:

  • To review platelet morphology and structural organization.
  • To summarize platelet function in physiological conditions, atherosclerosis, and post-cardiovascular device implantation.
  • To highlight the role of platelet function in thromboembolic events.

Main Methods:

  • Literature review of studies on platelet function.
  • Description of platelet ultrastructure, including membrane receptors, organelle systems, cytoskeleton, and granules.
  • Summary of platelet activity in various clinical contexts.

Main Results:

  • Detailed description of platelet components: membrane receptors, canalicular and tubular systems, cytoskeleton, mitochondria, granules, lysosomes, and peroxisomes.
  • Overview of platelet function under normal physiological conditions.
  • Analysis of altered platelet function in atherosclerotic patients.
  • Examination of platelet response following cardiovascular device implantation.

Conclusions:

  • Platelet structure and function are critical in understanding thromboembolic events.
  • Further research is needed on platelet function as a risk factor in atherosclerosis.
  • Understanding platelet behavior is essential for managing patients with atherosclerosis and cardiovascular devices.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.5K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
915
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K